Terumo Corporation

Microvention, Inc.

Cortex Pharmaceuticals, Inc.

Valeant Research and Development

Clayton Harris

Gregory M Cruise

Gloria Hincapie

Edward Michael Keeley

Michael J Constant

Steve Plotkin

Rob Greene

Renee Yu

Yue Wu

Haoyun An

Gary A Rogers

Rudolf Mueller

Jim Zhen Wu

Christopher M Marrs

Frank Rong

Suetying Chow

Matthew Allan

Jianjie Huang

Stanislaw Rachwal

Michael Keeley Edward

M Cruise Gregory

Polymer particle embolics and methods of making same are described. The particle embolics can be used as embolization agents.

Polymer particles

Polymeric compositions are described comprising a biocompatible polymer including a biodegradable linkage to a visualization agent and a non-physiological solution; wherein the biocompatible polymer is soluble in the non-physiological solution and insoluble in a physiological solution. Methods of forming the solutions and polymers are disclosed as well as methods of therapeutic use.

Polymeric treatment compositions

Biodegradable, cross-linked polymer particle embolics and methods of making the same are described. The particle embolics can be used as embolization agents.

Biodegradable, cross-linked polymer films and methods of making the same are described. The polymer films can be used for preventing adhesions following surgery and/or delivering therapeutic agents.

Polymer films

Polymers are described herein comprising: a reaction product of a prepolymer solution including at least one macromer and at least one visualization agent; and an active agent electrostatically bound to the polymer filament or chemically bound to the at least one monomer; wherein the polymer filament does not include metallic support members.

Polymers including active agents

Polymeric compositions are described comprising a biocompatible polymer including a biodegradable linkage to a visualization agent and a non-physiological pH solution; wherein the biocompatible polymer is soluble in the non-physiological pH solution and insoluble at a physiological pH. Methods of forming the solutions and polymers are disclosed as well as methods of therapeutic use.

Polymer filaments including pharmaceutical agents and delivering same

Growing community of inventors

Tustin, CA, United States of America

Clayton Harris